Arteriovenous malformations future or investigational therapies: Difference between revisions
(Created page with "__NOTOC__ {{Arteriovenous malformations}} {{CMG}}; {{AE}} {{KD}} ==Overview== The optimal management of AVMs remains an ongiong topic of clinical research. <ref>[http://www.c...") |
(No difference)
|
Revision as of 17:14, 30 January 2013
Arteriovenous malformations Microchapters |
Differentiating Arteriovenous malformations from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Arteriovenous malformations future or investigational therapies On the Web |
American Roentgen Ray Society Images of Arteriovenous malformations future or investigational therapies |
FDA on Arteriovenous malformations future or investigational therapies |
CDC on Arteriovenous malformations future or investigational therapies |
Arteriovenous malformations future or investigational therapies in the news |
Blogs on Arteriovenous malformations future or investigational therapies |
Directions to Hospitals Treating Arteriovenous malformations |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Overview
The optimal management of AVMs remains an ongiong topic of clinical research. [1].